More than 200 brands spoke out in the week that followed Hamas’ terrorist attacks against Israel a year ago. Yet companies grew more silent in the months that followed.
Skyrizi notches top pharma, Rx brand spot for Q3 2024
The arrival of Overdrive comes as the U.S. endures the so-called ‘fourth wave’ of the multi-decade opioid epidemic, which has killed millions of Americans.
How beauty and brands are evolving in the Ozempic era
With beauty standards increasingly shaped by quick-fix solutions, Quantum’s Tanya Malik questions whether brands are prepared for the profound shifts in consumer expectations, and how they’ll adapt to this new reality.
80% of brands worried about agency use of gen AI, WFA survey finds
Several brands have publicly abandoned DE&I efforts. Marketers warn these decisions will negatively impact their businesses in the short and long term.